Question to the Department of Health and Social Care:

To ask His Majesty's Government how many suspected breaches of the Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024 (SI 2024/1319) have been (1) reported to, and (2) investigated by the medicines and healthcare products regulatory agency since 1 January 2025; and what enforcement action has resulted.

In August 2025, the Government launched a call for evidence on private, non-National Health Service prescribing, which included an invitation for views on online prescribing, hormone prescribing, and prescribing by practitioners based in the European Economic Area. We are considering the evidence and next steps.

Since 1 January 2025, the Medicines and Healthcare products Regulatory Agency has received three reports of suspected breaches of the Order cited by the Noble Baroness. All three reports were investigated, but no offences were identified and no criminal enforcement action was taken. In one case, the agency referred safeguarding concerns to the relevant local multi-agency safeguarding team, notified the relevant European regulatory authority about the prescribing doctor’s activities, and passed information about a possible breach by a registered pharmacy to the General Pharmaceutical Council.